Clinical Trials in Illinois

Showing 2761-2780 of 19,692 trials

Fast Induced Remodeling in Heart Failure With Preserved Ejection Fraction

NCT05839730

FIRE-HFpEF is a multi-center, prospective, randomized, single-blinded, clinical feasibility study. This study will enroll up to 105 subjects with heart failure with preserved ejection fraction in the United States. Data will be collected to evaluate whether pacing therapies can lead to improvements in exercise capacity and health status of subjects.

Heart Failure With Preserved Ejection FractionConcentric Hypertrophy

Medtronic Cardiac Rhythm and Heart Failure105 participantsStarted Sep 2024

Naples, Florida, United States • O'Fallon, Illinois, United States • Springfield, Illinois, United States +6 more locations

Active Not RecruitingPhase 397 miles

A Study to Compare ABP 234 and Keytruda® (Pembrolizumab) in Participants With Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer

NCT06311721

The primary objective of this study is to compare the efficacy of ABP 234 with the pembrolizumab reference product (Keytruda®).

Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer

Amgen315 participantsStarted Sep 2024

Beverly Hills, California, United States • Cerritos, California, United States • Los Alamitos, California, United States +216 more locations

Fast Induced Remodeling in Heart Failure With Preserved Ejection Fraction

A Study to Compare ABP 234 and Keytruda® (Pembrolizumab) in Participants With Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer

Find Trials by Condition in Illinois

EvaLuate EndoVascular Treatment of Acutely Ruptured Shallow Intradural Aneurysms With the Pipeline™ Flex Embolization Device With Shield TEchnology™ (ELEVATE)

Efficacy and Safety of Tezepelumab in Participants With Severe Chronic Rhinosinusitis With Nasal Polyposis

Comparing Antibiotic Treatment Strategies for Children With Pneumonia in Outpatient Settings: (STAMPP)

Multicenter Orthopaedic Outcomes Network (MOON) ACL Reconstruction (ACLR): Onsite Follow-up

Gevokizumab With Standard of Care Anti-cancer Therapies for Metastatic Colorectal, Gastroesophageal, and Renal Cancers

Vorinostat for Graft vs Host Disease Prevention in Children, Adolescents and Young Adults Undergoing Allogeneic Blood and Marrow Transplantation

Platform Trial Evaluating Safety and Efficacy of Ezabenlimab Anti- PD-1 Based Combination Therapies in PD-(L)1 naïve and PD- (L)1 Pretreated Patient Populations With Advanced/Metastatic Solid Tumours

PIONEER III Trial to Assess Safety and Efficacy of the BuMA Supreme™ Drug Coated Coronary Stent in Patients With Coronary Disease

Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions

Cervical Plexus Hydrodissection With D5W for PTSD

A Proof of Concept and Dose-finding Study of XXB750 in Patients With Heart Failure

EZH2 Inhibitor, Tulmimetostat, and PD-1 Blockade for Treatment of Advanced Non-small Cell Lung Cancer

Improvement of PPROM Management With Prophylactic Antimicrobial Therapy (iPROMPT)

EXHIT ENTRE Implementation Trial of High Intensity Versus Low Intensity Strategy

Comparing Game Facilitated Interactivity to Genetic Counseling for Prenatal Screening Education

BOLD-100 in Combination With FOLFOX for the Treatment of Advanced Solid Tumours

A Placebo-controlled Safety and Tolerability Study of Intravenous (IV) and Subcutaneous (SC) AZD1163 in Healthy Volunteers

The SUGAR Study; SBRT and Relugolix) for Prostate Cancer